Files

657808.pdf (115.82 KB)

Document type

Article

Version

Submitted version

Publication date

2016-03-15

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/107804

Impact of the functional CD5 polymorphism A471V on the response of chronic lymphocytic leukaemia to conventional chemotherapy regimens.

Journal Title

Authors

Director/Tutor

Additional contribution

Journal ISSN

Volume Title

Abstract

Chronic lymphocytic leukaemia (CLL) represents an abnormal clonal expansion of mature antigen-experienced CD5+ B1a cells (Chiorazzi et al, 2005), which present with a highly heterogeneous clinical course depending on associated chromosomal aberrations, somatic mutations within the immunoglobulin variable heavy chain genes (IGHV), and surface CD38 or intracytoplasmic ZAP-70 expression. Given that key signalling components of the B-cell receptor (BCR) are relevant contributors to the variable clinical behaviour of CLL (Stevenson et al, 2011) we explored the influence of functionally relevant germline CD5 variants on CLL prognosis.

Related resource

https://doi.org/10.1111/bjh.14037

Subject

Leucèmia limfocítica crònica, Receptors cel·lulars, Cèl·lules B, Biologia molecular, Immunologia

Subject (English)

Chronic lymphocytic leukemia, Cell receptors, B cells, Molecular biology, Immunology

Citation

Collections

Articles publicats en revistes (Biomedicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citation

DELGADO, Julio (Delgado González), et al. Impact of the functional CD5 polymorphism A471V on the response of chronic lymphocytic leukaemia to conventional chemotherapy regimens. British Journal of Haematology. 2017. Vol. 177, num. 1, pags. 147-150. ISSN 0007-1048. [consulted: 10 of October of 2026]. Available at: https://hdl.handle.net/2445/107804

Export metadata

JSON - METS

Share record